
|Videos|August 26, 2021
Role of Venetoclax in Treatment of AML
Expert discusses the role of venetoclax in the treatment of AML and if achievement of MRD negativity can be used to predict long-term outcomes.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Ziftomenib Receives FDA Approval for Acute Myeloid Leukemia With NPM1 Mutations
3
Giredestrant Plus Everolimus Extends Survival in ER+, HER2- Advanced Breast Cancer
4
The Dual Burden of CAR T-Cell Therapy: Financial and Time Toxicity in the Era of Precision Oncology
5























































































































































































































